ReviewCurrent hematologic malignancy reports2017

Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies.

Tarsheen K Sethi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.